Implant Sciences Explosives Trace Detection Equipment to Be Deployed at the Summit of the Americas
Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that the Colombian National Police has selected Implant Sciences explosives trace detection equipment as part of the security plan for the Summit of the Americas. Both the Quantum Sniffer™ QS-H150 handheld explosives trace detectors and the Quantum Sniffer™ QS-B220 benchtop narcotics and explosives trace detectors will be used at the Sixth Summit of the Americas, where 34 heads of state and government of the Americas will convene in Cartagena, Colombia on April 14 and 15, 2012.
Implant Sciences systems will be deployed at entry checkpoints as the primary explosives screening mechanism for people, bags, and briefcases in a layered security environment.
Global GIS Market in the Transportation Industry 2016-2020
The Summit of the Americas are institutionalized gatherings of the heads of state and government of the Western Hemisphere where leaders discuss common policy issues, affirm shared values and commit to concerted actions at the national and regional level to address continuing and new challenges faced in the Americas.
"I appreciate the effort that Implant Sciences and their local representatives have put into making it possible for us to use the QS-H150 and QS-B220 during the Summit of the Americas," commented Mayor General José Roberto León Riaño, Subdirector General of the Colombian National Police. "It is very encouraging to see such cooperation in ensuring a safe and peaceful event, and I look forward to working with them in the future."
Implant Sciences President and CEO Glenn D. Bolduc added, "Our equipment has been selected to provide trace detection for the most important political summit of our hemisphere because of its proven performance in a wide range of applications. We are working closely with the Colombian National Police on delivery, set up and implementation of our handheld and benchtop units. This is an opportunity for us to not only provide security at this critical event, but also to receive additional exposure for our products in front of key governmental decision makers from South, Central, and North America."
Source : Implant Sciences Corp.
Mar 29 - 30, 2017 - London, United Kingdom